Fresenius Medical Care AG ADR
Fresenius Medical Care AG ADR (FMS) Covered Calls
As of September 25, 2026, FMS has 2 covered call opportunities in the coming three months. Return ranges from 7.4 to 34.5% until expiration. Annualized return ranges from 13.2 to 111.3%. The nearest expiration is January 15, 2027. Maximum potential profit is $770.
Read more
Running FMS covered calls helps you generate consistent income from Fresenius Medical Care AG ADR's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Fresenius Medical Care AG ADR involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best FMS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if FMS stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling FMS covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Fresenius Medical Care AG ADR covered call is worth writing.
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Income-focused investors, long-term FMS holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling FMS covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Fresenius Medical Care AG ADR covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Care Facilities
- SectorHealthcare
- IV percentile84.52% Elevated
- Market cap (M$)12,076
- 52 weeks high-17.91%
- 52 weeks low13.34%
- Analyst recommendationSell
4.00 - Target price$20.80
-8.33% below the current stock price - Dividend—
- Payout ratio31.98%
- Earnings date2026-11-03
- P/E11.71
- Future P/E9.26
- EPS (ttm)1.94
- EPS growth next 5 years3.98%
As of September 25, 2026
| 2027-01-15 | 113 | 30.00 | 34.23 | 0.05 | 2.80 | 770.00 | 34.45 | 111.28 | -0.22 | +0.31 | 6 | 2.75 |
| 2027-04-16 | 204 | 22.50 | 0.67 | 1.50 | 3.90 | 165.00 | 7.38 | 13.21 | -6.71 | +0.58 | 0 | 2.40 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best FMS covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→